Received Oct 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (QUADRACEL) | SANOFI PASTEUR | 2 | U8623AA | IM / LL |
| FLU3 | INFLUENZA (SEASONAL) (FLUCELVAX) | SEQIRUS, INC. | UNK | 410514 | IM / RL |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Z005472 | IM / LL |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z009665 | SC / RL |
Large red rash, moderate itching, significant swelling of the injection site, pain ? all symptoms developed within 24 hours of the injection of the MMRV vaccine (had a previous reaction in March 2023 to the same vaccine). Treated with children's Benadryl, administered ibuprofen, alternating heat and ice ? treatment still ongoing.
N/A
N/A
N/A
N/A
MMRV subq vaccine, given March 2023 at age 4. Same symptoms, developed hives around the area as well.